Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED)

v3.19.3
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2017 234,076,907      
Beginning balance, value at Dec. 31, 2017 $ 234,077 $ 108,000,923 $ (110,109,000) $ (1,874,000)
Common stock issued on exercise of warrants and options, shares 12,697,483      
Common stock issued on exercise of warrants and options, value $ 12,697 634,303   647,000
Common stock issued on conversion of notes payable, shares 7,374,125      
Common stock issued on conversion of notes payable, value $ 7,374 466,626   474,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   526,000   526,000
Fair value of options and warrants issued as compensation   340,000   340,000
Common stock issued for services, shares 50,000      
Common stock issued for services, value $ 50 11,950   12,000
Net loss     (2,139,000) (2,139,000)
Ending balance, shares at Sep. 30, 2018 254,198,515      
Ending balance, value at Sep. 30, 2018 $ 254,198 109,979,802 (112,248,000) (2,014,000)
Beginning balance, shares at Jun. 30, 2018 251,448,515      
Beginning balance, value at Jun. 30, 2018 $ 251,448 109,543,552 (111,567,000) (1,772,000)
Common stock issued on conversion of notes payable, shares 2,750,000      
Common stock issued on conversion of notes payable, value $ 2,750 134,250   137,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   207,000   207,000
Fair value of options and warrants issued as compensation   95,000   95,000
Net loss     (681,000) (681,000)
Ending balance, shares at Sep. 30, 2018 254,198,515      
Ending balance, value at Sep. 30, 2018 $ 254,198 109,979,802 (112,248,000) (2,014,000)
Beginning balance, shares at Dec. 31, 2018 256,123,515      
Beginning balance, value at Dec. 31, 2018 $ 256,123 111,429,877 (113,168,000) (1,482,000)
Common stock issued on exercise of warrants and options, shares 4,039,690      
Common stock issued on exercise of warrants and options, value $ 4,040 287,960   292,000
Common stock issued on conversion of notes payable, shares 42,271,760      
Common stock issued on conversion of notes payable, value $ 42,272 2,311,728   2,354,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   1,350,000   1,350,000
Fair value of options and warrants issued as compensation   275,000   275,000
Common stock issued for services, shares 250,000      
Common stock issued for services, value $ 250 67,750   68,000
Net loss     (4,728,000) (4,728,000)
Ending balance, shares at Sep. 30, 2019 302,684,965      
Ending balance, value at Sep. 30, 2019 $ 302,685 115,722,315 (117,896,000) (1,871,000)
Beginning balance, shares at Jun. 30, 2019 298,457,191      
Beginning balance, value at Jun. 30, 2019 $ 298,456 115,085,544 (116,908,000) (1,524,000)
Common stock issued on exercise of warrants and options, shares 362,500      
Common stock issued on exercise of warrants and options, value $ 363 18,637   19,000
Common stock issued on conversion of notes payable, shares 3,865,274      
Common stock issued on conversion of notes payable, value $ 3,866 305,134   309,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   232,000   232,000
Fair value of options and warrants issued as compensation   81,000   81,000
Net loss     (988,000) (988,000)
Ending balance, shares at Sep. 30, 2019 302,684,965      
Ending balance, value at Sep. 30, 2019 $ 302,685 $ 115,722,315 $ (117,896,000) $ (1,871,000)